Vaccine Manufacturing

The rising prevalence of several diseases and the emergence of several new ones are expected to encourage the development of novel and effective drugs and vaccines, according to a market research study by Transparency Market Research. In 2016, the global vaccines market was worth $28 billion and is projected to reach a value of $48 billion by the end of 2025, notes the study. The market is predicted to register a 6% CAGR between 2017 and 2025.

Genetic Engineering & Biotechnology News (GEN) interviewed Mannan Khambati, of Bharat Serums & Vaccines, India, and George O. Lovrecz, PhD, adjunct professor of RMIT and Monash University, and Senior Principal Research scientist, CSIRO Protein Production and Fermentation, Australia, to get a better sense of the manufacturing and economic issues involved in vaccine development.